Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Pham Quang X
Chairman and CEO at Cadrenal Therapeutics. Filing since 1 Sep 2023.
CIK 0001405290
Company
Date
Role
Action
Shares
Amount
Of holding
CVKD
Cadrenal Therapeutics, Inc.
29 Jun 2026
Chairman and CEO
Sold on a plan
7,400
$22.42K
7.0%
CVKD
Cadrenal Therapeutics, Inc.
26 Jun 2026
Chairman, CEO and Interim CFO
Sold on a plan
9,029
$27.54K
7.9%
CVKD
Cadrenal Therapeutics, Inc.
25 Jun 2026
Chairman, CEO and Interim CFO
Sold on a plan
2,127
$6.38K
1.8%
CVKD
Cadrenal Therapeutics, Inc.
23 Jun 2026
Chairman, CEO and Interim CFO
Sold on a plan
2,277
$7.29K
1.9%
CVKD
Cadrenal Therapeutics, Inc.
22 Jun 2026
Chairman, CEO and Interim CFO
Sold on a plan
9,167
$32.54K
7.1%
CVKD
Cadrenal Therapeutics, Inc.
17 Jun 2026
Chairman, CEO and Interim CFO
Sold on a plan
513
$1.62K
0.4%
CVKD
Cadrenal Therapeutics, Inc.
16 Jun 2026
Chairman, CEO and Interim CFO
Sold on a plan
3,613
$11.49K
2.7%
CVKD
Cadrenal Therapeutics, Inc.
15 Jun 2026
Chairman, CEO and Interim CFO
Sold at will
3,666
$13.12K
2.7%
CVKD
Cadrenal Therapeutics, Inc.
12 Jun 2026
Chairman, CEO and Interim CFO
Sold at will
12,996
$51.20K
8.7%
CVKD
Cadrenal Therapeutics, Inc.
11 Jun 2026
Chairman, CEO and Interim CFO
Sold at will
1,462
$6.02K
1.0%
CVKD
Cadrenal Therapeutics, Inc.
10 Jun 2026
Chairman, CEO and Interim CFO
Sold on a plan
3,500
$14.74K
2.3%
CVKD
Cadrenal Therapeutics, Inc.
9 Jun 2026
Chairman, CEO and Interim CFO
Sold on a plan
12,992
$52.75K
7.8%
CVKD
Cadrenal Therapeutics, Inc.
8 Jun 2026
Chairman, CEO and Interim CFO
Sold on a plan
5,893
$25.81K
3.4%
CVKD
Cadrenal Therapeutics, Inc.
5 Jun 2026
CEO and Chairman
Sold on a plan
2,064
$9.12K
1.2%
CVKD
Cadrenal Therapeutics, Inc.
4 Jun 2026
CEO and Chairman
Sold on a plan
3,898
$17.19K
2.2%
CVKD
Cadrenal Therapeutics, Inc.
3 Jun 2026
CEO and Chairman
Sold on a plan
2,323
$9.90K
1.3%
CVKD
Cadrenal Therapeutics, Inc.
2 Jun 2026
CEO and Chairman
Sold on a plan
349
$1.56K
0.2%
CVKD
Cadrenal Therapeutics, Inc.
29 May 2026
CEO and Chairman
Sold on a plan
303
$1.52K
0.2%
CVKD
Cadrenal Therapeutics, Inc.
28 May 2026
CEO and Chairman
Sold on a plan
2,989
$14.74K
1.6%
CVKD
Cadrenal Therapeutics, Inc.
22 May 2026
CEO and Chairman
Sold on a plan
1,165
$6.63K
0.6%
CVKD
Cadrenal Therapeutics, Inc.
12 May 2026
CEO and Chairman
Sold on a plan
3,298
$17.41K
1.8%
CVKD
Cadrenal Therapeutics, Inc.
11 May 2026
CEO and Chairman
Sold on a plan
6,476
$37.30K
3.3%
CVKD
Cadrenal Therapeutics, Inc.
27 Oct 2025
CEO and Chairman
Sold on a plan
1,315
$18.40K
0.7%
CVKD
Cadrenal Therapeutics, Inc.
24 Oct 2025
CEO and Chairman
Sold on a plan
1,129
$15.84K
0.6%
CVKD
Cadrenal Therapeutics, Inc.
13 Oct 2025
CEO and Chairman
Sold on a plan
1,800
$25.47K
0.9%
CVKD
Cadrenal Therapeutics, Inc.
9 Oct 2025
CEO and Chairman
Sold on a plan
1,800
$25.24K
0.9%
CVKD
Cadrenal Therapeutics, Inc.
2 Oct 2025
CEO and Chairman
Sold on a plan
500
$7.07K
0.2%
CVKD
Cadrenal Therapeutics, Inc.
1 Oct 2025
CEO and Chairman
Sold on a plan
881
$12.34K
0.4%
CVKD
Cadrenal Therapeutics, Inc.
29 Sep 2025
CEO and Chairman
Sold on a plan
419
$5.87K
0.2%
CVKD
Cadrenal Therapeutics, Inc.
25 Sep 2025
CEO and Chairman
Sold on a plan
6,790
$95.67K
3.2%
CVKD
Cadrenal Therapeutics, Inc.
24 Sep 2025
CEO and Chairman
Sold on a plan
2,581
$36.11K
1.2%
CVKD
Cadrenal Therapeutics, Inc.
28 Aug 2025
CEO and Chairman
Sold on a plan
1,193
$16.69K
0.6%
CVKD
Cadrenal Therapeutics, Inc.
27 Aug 2025
CEO and Chairman
Sold on a plan
3,836
$53.67K
1.8%
CVKD
Cadrenal Therapeutics, Inc.
5 Sep 2023
CEO and Chairman
Bought
40,000
$36.19K
1.2%
CVKD
Cadrenal Therapeutics, Inc.
1 Sep 2023
CEO and Chairman
Bought
70,000
$63.95K
2.1%
35 decisions on file.
